Search Results
You are looking at 1 - 1 of 1 items for
- Author: Sari I Mäkelä x
- Refine by access: All content x
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Search for other papers by Matias Knuuttila in
Google Scholar
PubMed
Search for other papers by Arfa Mehmood in
Google Scholar
PubMed
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Search for other papers by Jenni Mäki-Jouppila in
Google Scholar
PubMed
Search for other papers by Henrik Ryberg in
Google Scholar
PubMed
Search for other papers by Pekka Taimen in
Google Scholar
PubMed
Search for other papers by Juha Knaapila in
Google Scholar
PubMed
Search for other papers by Otto Ettala in
Google Scholar
PubMed
Search for other papers by Peter J Boström in
Google Scholar
PubMed
Search for other papers by Claes Ohlsson in
Google Scholar
PubMed
Search for other papers by Mikko S Venäläinen in
Google Scholar
PubMed
Search for other papers by Asta Laiho in
Google Scholar
PubMed
Search for other papers by Laura L Elo in
Google Scholar
PubMed
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Search for other papers by Petra Sipilä in
Google Scholar
PubMed
Functional Foods Forum, University of Turku, Turku, Finland
Search for other papers by Sari I Mäkelä in
Google Scholar
PubMed
Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland
Center for Bone and Arthitis Research, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Matti Poutanen in
Google Scholar
PubMed
Intratumoral androgen biosynthesis is one of the mechanisms involved in the progression of prostate cancer, and an important target for novel prostate cancer therapies. Using gas chromatography-tandem mass spectrometry and genome-wide RNA sequencing, we have analyzed androgen concentrations and androgen-regulated gene expression in cancerous and morphologically benign prostate tissue specimens and serum samples obtained from 48 primary prostate cancer patients. Intratumoral dihydrotestosterone (DHT) concentrations were significantly higher in the cancerous tissues compared to benign prostate (P < 0.001). The tissue/serum ratios of androgens were highly variable between the patients, indicating individual patterns of androgen metabolism and/or uptake of androgens within the prostate tissue. An unsupervised hierarchical clustering analysis of intratissue androgen concentrations indicated that transmembrane protease, serine 2/ETS-related gene (TMPRSS2-ERG)-positive patients have different androgen profiles compared to TMPRSS2-ERG-negative patients. TMPRSS2-ERG gene fusion status was also associated with an enhanced androgen-regulated gene expression, along with altered intratumoral androgen metabolism, demonstrated by reduced testosterone concentrations and increased DHT/testosterone ratios in TMPRSS2-ERG-positive tumors. TMPRSS2-ERG-positive and -negative prostate cancer specimens have distinct intratumoral androgen profiles, possibly due to activation of testosterone-independent DHT biosynthesis via the alternative pathway in TMPRSS2-ERG-positive tumors. Thus, patients with TMPRSS2-ERG-positive prostate cancer may benefit from novel inhibitors targeting the alternative DHT biosynthesis.